Description
The necessity for Russia to further develop its innovative drug R&D cannot be overstated. According to governmental strategy for the pharmaceutical industry up to 2020 (Pharma`2020), Russian innovative drugs should make up at least half of all available products in the Russian pharmaceutical market. To achieve such a result, it is vital to focus on stimulating the development and production of innovative drugs in Russia.
This forum will discuss the optimal strategies for success in the research, development and production of innovative drugs in Russia, with practical case studies from both Russian and international companies.
The programme for this 2-day event features a balanced mix of plenary sessions, key regulatory presentations, interactive discussions and debates, to ensure that you benefit from a broad range of opinions, gain maximum insight into this strategic sector, and have your business-critical questions answered by the panel of 30+ expert speakers.
